Skip to content

Bayer Receives $1.56 Billion Verdict in Roundup Cancer Lawsuit

In a stunning legal defeat, Bayer, the German pharmaceutical and agricultural chemical giant, has been ordered to pay $1.56 billion to four plaintiffs who claimed the company’s popular herbicide Roundup caused serious injuries, including cancer. This latest verdict in a Missouri court marks Bayer’s fourth consecutive loss in a series of Roundup-related lawsuits, raising concerns among investors and intensifying pressure on the company to reconsider its legal strategy.

According to court documents, a jury in Cole County, Missouri, found Bayer’s Monsanto business liable for negligence, design defects and failing to warn the plaintiffs about the potential dangers of using Roundup. The jury awarded a total of $61.1 million in compensatory damages and $500 million each in punitive damages to three plaintiffs diagnosed with non-Hodgkin’s lymphoma, allegedly caused by exposure to Roundup on their properties.

Bayer maintains that decades of scientific studies support the safety of Roundup and its active ingredient, glyphosate. However, the recent series of legal setbacks raises questions about the company’s handling of the Roundup litigation and its potential impact on Bayer’s reputation and financial stability.

Bayer has expressed its intention to appeal the recent rulings, arguing that the courts have allowed the plaintiffs to misrepresent crucial scientific assessments by the European Union and the US Environmental Protection Agency about the safety of glyphosate.

This case is part of a larger wave of litigation that includes approximately 165,000 claims against Bayer alleging personal injuries caused by Roundup. In 2020, the company settled the most pending cases for a maximum of $10.9 billion. However, some 50,000 claims remain unresolved, leaving Bayer facing significant legal challenges ahead.

As this legal battle unfolds, Bayer shareholders, including Union Investment, one of its top 10 investors, have urged the company to consider settling more cases to mitigate the financial and reputational risks associated with the ongoing litigation.

The Roundup saga continues to be closely watched by legal experts, consumers and public health advocates, as the outcome of these cases could have far-reaching implications for Bayer and the broader use of glyphosate-based herbicides.

the mail Bayer Receives $1.56 Billion Verdict in Roundup Cancer Lawsuit appeared first


Leave a Reply

Your email address will not be published. Required fields are marked *